Patterns of failure after trimodality therapy for malignant pleural mesothelioma

Elizabeth Healey Baldini*, Abram Recht, Gary M. Strauss, Malcolm M. DeCamp, Scott J. Swanson, Michael J. Liptay, Steven J. Mentzer, David J. Sugarbaker

*Corresponding author for this work

Research output: Contribution to journalArticle

240 Scopus citations

Abstract

Background. Malignant pleural mesothelioma is uncommon, and presently, no standard treatment of this disease exists. The objective of our analysis was to study the patterns of failure for malignant pleural mesothelioma after trimodality treatment consisting of extrapleural pneumonectomy, chemotherapy, and radiation therapy. Methods. Between 1987 and 1993, 49 patients with malignant pleural mesothelioma underwent extrapleural pneumonectomy. There were two perioperative deaths, and 1 patient died 5 weeks after extrapleural pneumonectomy. Thirty-five of the surviving patients received adjuvant chemotherapy (32/35 received cyclophosphamide, doxorubicin, and cisplatin) followed by hemithorax radiation therapy. Ten patients received chemotherapy but no radiation therapy, and 1 patient received no adjuvant therapy. Median follow-up time for the 23 living patients from the date of operation was 18 months. Results. Of the 46 evaluable patients, 25 had recurrence (54%), with a median time to first failure of 19 months (range, 5 to 51 months). The sites of first recurrence were local in 35% of patients, abdominal in 26%, the contralateral thorax in 17%, and other distant sites in 8%. (Some patients had recurrence in multiple sites simultaneously.) Conclusions. The most common site of failure after trimodality therapy was the ipsilateral hemithorax. Isolated distant failures were uncommon. Future strategies should investigate methods of enhancing local tumor control.

Original languageEnglish (US)
Pages (from-to)334-338
Number of pages5
JournalAnnals of Thoracic Surgery
Volume63
Issue number2
DOIs
StatePublished - Feb 1 1997

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Patterns of failure after trimodality therapy for malignant pleural mesothelioma'. Together they form a unique fingerprint.

  • Cite this

    Baldini, E. H., Recht, A., Strauss, G. M., DeCamp, M. M., Swanson, S. J., Liptay, M. J., Mentzer, S. J., & Sugarbaker, D. J. (1997). Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Annals of Thoracic Surgery, 63(2), 334-338. https://doi.org/10.1016/S0003-4975(96)01228-3